|
1
|
Aydar E, Palmer CP and Djamgoz MB: Sigma
receptors and cancer: Possible involvement of ion channels. Cancer
Res. 64:5029–5035. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quirion R, Bowen WD, Itzhak Y, Junien JL,
Musacchio JM, Rothman RB, Su TP, Tam SW and Taylor DP: A proposal
for the classification of sigma binding sites. Trends Pharmacol
Sci. 13:85–86. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanner M, Moebius FF, Flandorfer A, Knaus
HG, Striessnig J, Kempner E and Glossmann H: Purification,
molecular cloning, and expression of the mammalian sigma1-binding
site. Proc Natl Acad Sci USA. 93:8072–8077. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hellewell SB and Bowen WD: A sigma-like
binding site in rat pheochromocytoma (PC12) cells: Decreased
affinity for (+)-benzomorphans and lower molecular weight suggest a
different sigma receptor form from that of guinea pig brain. Brain
Res. 527:244–253. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hayashi T and Su TP: Sigma-1 receptor
chaperones at the ER-mitochondrion interface regulate Ca(2+)
signaling and cell survival. Cell. 131:596–610. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aydar E, Palmer CP, Klyachko VA and
Jackson MB: The receptor as a ligand-regulated auxiliary potassium
channel subunit. Neuron. 34:399–410. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Palmer CP, Mahen R, Schnell E, Djamgoz BA
and Aydar E: Sigma-1 receptors bind cholesterol and remodel lipid
rafts in breast cancer cell lines. Cancer Res. 67:11166–11175.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu UB and Ruoho AE: Biochemical
pharmacology of the sigma-1 receptor. Mol Pharmacol. 89:142–153.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu Z and Bowen WD: Role of sigma-1
receptor C-terminal segment in inositol 1,4,5-trisphosphate
receptor activation: Constitutive enhancement of calcium signaling
in MCF-7 tumor cells. J Biol Chem. 283:28198–28215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maurice T and Su TP: The pharmacology of
sigma-1 receptors. Pharmacol Ther. 124:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vilner BJ, John CS and Bowen WD: Sigma-1
and sigma-2 receptors are expressed in a wide variety of human and
rodent tumor cell lines. Cancer Res. 55:408–413. 1995.PubMed/NCBI
|
|
12
|
van Waarde A, Rybczynska AA, Ramakrishnan
NK, Ishiwata K, Elsinga PH and Dierckx RA: Potential applications
for sigma receptor ligands in cancer diagnosis and therapy. Biochim
Biophys Acta. 1848:2703–2714. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brent PJ and Pang GT: Sigma binding site
ligands inhibit cell proliferation in mammary and colon carcinoma
cell lines and melanoma cells in culture. Eur J Pharmacol.
278:151–160. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moody TW, Leyton J and John C: Sigma
ligands inhibit the growth of small cell lung cancer cells. Life
Sci. 66:1979–1986. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim FJ, Schrock JM, Spino CM, Marino JC
and Pasternak GW: Inhibition of tumor cell growth by Sigma1 ligand
mediated translational repression. Biochem Biophys Res Commun.
426:177–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Erin M and Kazanietz GG: Protein kinase C
and other diacylglycerol effector in cancer. Nat Rev Cancer.
7:281–294. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishizuka Y: The molecular heterogeneity
of protein kinase C and its implications for cellular regulation.
Nature. 334:661–665. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ono Y, Fujii T, Ogita K, Kikkawa U,
Igarashi K and Nishizuka Y: The structure, expression, and
properties of additional members of the protein kinase C family. J
Biol Chem. 263:6927–6932. 1988.PubMed/NCBI
|
|
19
|
Kang JH: Protein kinase C (PKC) isozymes
and cancer. New J Sci. 2014:2314182014. View Article : Google Scholar
|
|
20
|
Gupta AK, Galoforo SS, Berns CM, Martinez
AA, Corry PM, Guan KL and Lee YJ: Elevated levels of ERK2 in human
breast carcinoma MCF-7 cells transfected with protein kinase C
alpha. Cell Prolif. 29:655–663. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Zhao L, Yang Z, Funder JW and Liu
JP: Telomerase is controlled by protein kinase Calpha in human
breast cancer cells. J Biol Chem. 273:33436–33442. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H and Weinstein IB: Protein kinase C
beta enhances growth and expression of cyclin D1 in human breast
cancer cells. Cancer Res. 66:11399–11408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pal D, Outram SP and Basu A: Upregulation
of PKCη by PKCε and PDK1 involves two distinct mechanisms and
promotes breast cancer cell survival. Biochim Biophy Acta.
1830:4040–4045. 2013. View Article : Google Scholar
|
|
24
|
Karp G, Maissel A and Livneh E: Hormonal
regulation of PKC: Estrogen up-regulates PKCeta expression in
estrogen responsive breast cancer cells. Cancer Lett. 246:173–181.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yi P, Feng Q, Amazit L, Lonard DM, Tsai
SY, Tsai MJ and O'Malley BW: Atypical protein kinase C regulates
dual pathways for degradation of the oncogenic coactivator
SRC-3/AIB1. Mol Cell. 29:465–476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Allen-Petersen BL, Carter CJ, Ohm AM and
Reyland ME: Protein kinase Cδ is required for ErbB2-driven mammary
gland tumorigenesis and negatively correlates with prognosis in
human breast cancer. Oncogene. 33:1306–1315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Servi B, Hermani A, Medunjanin S and
Mayer D: Impact of PKCdelta on estrogen receptor localization and
activity in breast cancer cells. Oncogene. 24:4946–4955. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gomperts B, Kramer IM and Tatham P: Signal
transduction. 2nd edition. Elsevier Academic Press; Fourth
printing: pp. 246–251. 2004
|
|
29
|
Tan ST, Liu SY and Wu B: TRIM29
overexpression promotes proliferation and survival of bladder
cancer cells through NF-KB signaling. Cancer Res Treat.
48:1302–1312. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu J, Welm B, Boucher KM, Ebbert MT and
Bernard PS: TRIM29 functions as a tumor suppressor in
nontumorigenic breast cells and invasive ER+ breast cancer. Am J
Pathol. 180:839–847. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oliva JL, Griner EM and Kazanietz MG: PKC
isozymes and diacylglycerol-regulated proteins as effectors of
growth factor receptors. Growth Factors. 23:245–252. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schlessinger J: Cell signaling by receptor
tyrosine kinases. Cell. 103:211–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gschwind A, Fischer OM and Ullrich A: The
discovery of receptor tyrosine kinases: Targets for cancer therapy.
Nat Rev Cancer. 4:361–370. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dorsam RT and Gutkind JS:
G-protein-coupled receptors and cancer. Nat Rev Cancer. 7:79–94.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fogh BS, Multhaupt HA and Couchman JR:
Protein kinase C, focal adhesions and the regulation of cell
migration. J Histochem Cytochem. 62:172–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Natsvlishvili N, Goguadze N, Zhuravliova E
and Mikeladze D: Sigma-1 receptor directly interacts with
Rac1-GTPase in the brain mitochondria. BMC Biochem. 16:112015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Naranatt PP, Akula SM, Zien CA, Krishnan
HH and Chandran B: Kaposi's sarcoma-associated herpesvirus induces
the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling
pathway in target cells early during infection: Implications for
infectivity. J Virol. 77:1524–1539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ways DK, Kukoly CA, deVente J, Hooker JL,
Bryant WO, Posekany KJ, Fletcher DJ, Cook PP and Parker PJ: MCF-7
breast cancer cells transfected with protein kinase C-alpha exhibit
altered expression of other protein kinase C isoforms and display a
more aggressive neoplastic phenotype. J Clin Invest. 95:1906–1915.
1995. View Article : Google Scholar : PubMed/NCBI
|
